Idexx Laboratories Inc (IDXX) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline...
Idexx Laboratories Inc (IDXX) currently trades at a P/E ratio of 40.16 (historical range: 33.05–62.65, median: 45.21), placing it at the 12th percentile — cheap relative to its history, P/S ratio of 9.89 (range: 7.52–14.94, 28th percentile — below its historical average), EV/EBITDA of 121.59 (range: 30.12–145.95, 71th percentile).
Idexx Laboratories Inc appears undervalued relative to its historical range, with most valuation metrics below their median levels.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 40.16 | 33.05 | 45.21 | 62.65 | 12th | cheap relative to its history |
| P/S Ratio | 9.89 | 7.52 | 10.54 | 14.94 | 28th | below its historical average |
| EV/EBITDA | 121.59 | 30.12 | 61.69 | 145.95 | 71th | above its historical average |
| FCF Yield | 0.01 | 0.00 | 0.01 | 0.02 | 28th | above its historical average |